Thr40 and Met122 are new partial loss-of-function natural mutations of the human melanocortin 1 receptor  by Jiménez-Cervantes, Celia et al.
Thr40 and Met122 are new partial loss-of-function natural mutations of
the human melanocortin 1 receptor
Celia Jime¤nez-Cervantes*, Silke Germer, Petra Gonza¤lez, Jesu¤s Sa¤nchez,
Concepcio¤n Olivares Sa¤nchez, Jose¤ Carlos Garc|¤a-Borro¤n
Department of Biochemistry and Molecular Biology, School of Medicine, University of Murcia, Apto 4021, 30100 Espinardo, Murcia, Spain
Received 3 August 2001; revised 9 October 2001; accepted 9 October 2001
First published online 23 October 2001
Edited by Ned Mantei
Abstract Activation by melanocortins of the melanocortin 1
receptor (MC1R), expressed in epidermal melanocytes, stimu-
lates melanogenesis. Human MC1R gene loss-of-function muta-
tions are associated with fair skin, poor tanning and increased
skin cancer risk. We identified two natural alleles : Ile40Thr,
probably associated with skin types I^II, and Val122Met.
Val122Met bound [125I][Nle4, D-Phe7]-K-melanocyte stimulating
hormone with lower affinity than the wild-type. Dose^response
curves of cAMP accumulation were right-shifted for both forms.
The Val122Met form failed to achieve maximal cAMP responses
comparable to the wild-type or Ile40Thr receptors. Thus, the
Ile40Thr and Val122Met variants are partial loss-of-function
natural mutations of MC1R. ß 2001 Federation of European
Biochemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
The melanocortin receptors (MCR) are a well de¢ned sub-
group of the G protein-coupled receptors (GPCR) family,
showing signi¢cant sequence similarity, from 40 to 60%. Com-
pared to other GPCRs, the MCRs are small (298^372 amino
acids), with short external amino- and internal carboxyl-ter-
mini. The second extracellular and ¢fth transmembrane (TM)
domains are also unusually short (reviewed in [1]). Their li-
gands derive from the precursor proopiomelanocortin, which
undergoes a complex and tissue-speci¢c posttranslational pro-
cessing, leading to ACTH, K-, L-, and Q-melanocyte stimulat-
ing hormone (MSH), collectively termed melanocortins, and
other bioactive peptides [2].
MC1R is the only MCR expressed in melanocytes [1], the
epidermal cells responsible for mammalian pigmentation. It
displays the typical characteristics of the GPCR family [3],
with seven TM fragments. In the mouse, its preferential ligand
is K-MSH, but the human receptor is equally responsive to
ACTH. Upon binding to MC1R in the melanocyte plasma
membrane, these hormones trigger the cAMP cascade and
activate melanogenesis [4]. Therefore K-MSH and ACTH
are critical for the regulation of skin pigmentation.
In the mouse, the gene encoding the 315 amino acids Mc1r
maps to the extension locus [5]. There are four naturally oc-
curring extension alleles: wild-type (E), sombre (Eso and
Esoÿ3J), tobacco (Etob), and recessive yellow (e). The gain-of-
function dominant Eso allele is associated with black pigmen-
tation and overexpression of the darker pigments known as
eumelanins, with respect to the lighter, yellowish to reddish,
pheomelanins. Another gain-of-function allele, Etob, also
causes dominant black pigmentation. Conversely, mice homo-
zygote for the loss-of-function e allele lack eumelanin and are
almost entirely yellow [5]. Therefore, a clear relationship exists
between Mc1r function, melanin type and fur color.
The human MC1R is a 317 amino acid protein. The MC1R
gene was independently cloned in 1992 by two groups, who
reported slightly di¡erent sequences [6,7]. Some of the di¡er-
ences might be sequencing errors [8], although others corre-
spond to real polymorphisms. Indeed, the MC1R gene is
highly polymorphic [9,10]. Human skin types are usually clas-
si¢ed into di¡erent groups, depending on their basal pigmen-
tation and sensitivity to UV solar radiation. The frequently
used modi¢ed Fitzpatrick’s scale for Caucasian skin considers
four di¡erent types, with increasing basal pigmentation and
UV-induced tanning response, from type I (fair skin, burns
easily, never tans), to type IV (dark skin, tans well, rarely
burns). Based on the key role of mouse Mc1r on pigmentation
in mice, an association of human MC1R variants and skin
type has been actively investigated. The best studied variants
are Val60Leu, Arg67Gln, Asp84Glu, Val92Met, Arg121His,
Arg142His, Arg151Cys, Ile155Thr, Arg160Trp, Arg163Gln,
Asp294His, all resulting from point mutations, and several
insertions as 86insA, and 537insC [11^17]. Some variants are
more frequent in individuals with sun-sensitive skin types I or
II than in persons with higher basal pigmentation and tanning
response [15^17]. In addition, their frequency is higher in
blonds or red heads than in black-haired subjects, thus also
relating hair color and MC1R [11,13,17]. The functional ef-
fects of these variants have been analyzed. Arg142His,
Arg151Cys, Arg160Trp and Asp294His are loss-of-function
alleles [14]. The situation is less clear for the Val60Leu, since
transfection studies strongly suggest that it may be a partial
loss-of-function mutation [14], but, on the other hand, asso-
ciation studies did not ¢nd any signi¢cant correlation with a
particular skin or hair phenotype [13,15,17]. In any case,
MC1R seems a major determinant of human skin type and
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hair color, and an impairment of receptor function appears
associated with fair skin type or red hair. Since pigmentation
and skin cancer are also related, MC1R is considered a genetic
factor of skin cancer risk [13,15,18,19].
In a study of MC1R allelic variants as related to skin type
and melanoma risk we identi¢ed two new variants in skin type
I or II individuals: Ile40Thr and Val122Met (GenBank acces-
sion numbers AY046528 and AY046529, respectively). These
variants were further studied since they are located in regions
potentially important for receptor function (¢rst and third
TM fragments [3]). A schematic representation of the struc-
ture of MC1R can also be found on our Web page (http//
www.um.es/bbmbi/melanocitos.htm). We show here that these
variants lead to impaired binding a⁄nity of MC1R for its
cognate ligands, and lower e⁄ciency of coupling to the
cAMP cascade.
2. Materials and methods
2.1. DNA extraction, ampli¢cation and cloning of MC1R
Genomic DNA was extracted from blood samples of healthy vol-
unteers, using the Wizard kit (Promega, Madison, WI, USA). The
entire coding sequence of the MC1R gene was ampli¢ed using primers
CCTAAGCTTACTCCTTCCTGCTTCCTGGACA (forward, match-
ing nucleotides 435^456) and CTGGAATTCACACTTAAAGCG-
CGTGCACCGC (reverse, matching nucleotides 1418^1439), designed
from the sequence reported in [6], GenBank database entry X65634,
containing added HindIII and EcoRI restriction sites (underlined).
The 1023 bp fragment was cloned in pcDNA3 (Invitrogen, Carlsbad,
CA, USA) by means of the added restriction sites. PCR was per-
formed using 0.5 Wg of target DNA, 0.35 Wg of each primer, 200
WM each dNTP and 2.5 U of the proofreading Pfu polymerase. Thirty
rounds of ampli¢cation were carried out with denaturation for 1 min
at 95‡C, annealing for 2 min at 68‡C and extension for 3 min at 72‡C,
with a ¢nal 10 min extension at 72‡C. Complete sequencing of two
PCR products, obtained in independent reactions, and of the cloned
inserts was performed in both strands.
2.2. Allele-speci¢c PCR (AS-PCR)
The forward primers CGGTGCCTGGAGGTGTCCAC (Fw-
Thr40) and CAGCTGGACAATGTCATTGACA (Fw-Met122),
where the 3P-terminal nucleotide responsible for speci¢city is shown
in bold, were designed for the speci¢c detection of the Ile40Thr and
Val122Met alleles. Both primers were used with the reverse primer
described above. PCR conditions were: 30 rounds of 1 min at 95‡C
for denaturing, 1 min at 68 or 64‡C for annealing of Fw-Thr40 and
Fw-Met122, respectively, and 90 s at 72‡C for extension, with a ¢nal
extension step of 10 min at 72‡C.
2.3. Transient expression of MC1R
HEK 293T cells were grown in six-well plates with RPMI 1640,
10% fetal calf serum, 100 U/ml penicillin and 100 Wg/ml streptomycin.
This cell line has been extensively used in previous studies of trans-
fected MCR genes, since it does not express endogenous K-MSH
binding sites [6,8]. Transfection was carried out with the Superfect
reagent (Qiagen, Paisley, UK), as per instructions, with 1.5 Wg plasmid
DNA/well. Three hours after adding the transfection mix, the medium
was removed. Cells were gently washed with 500 Wl phosphate-bu¡-
ered saline (PBS) and 1 ml of fresh medium was added. After 24 h,
cells were completely serum-deprived for an additional 24 h before
binding or coupling assays.
2.4. Radioligand binding assay
Transfected cells were incubated (1 h, 37‡C) with increasing con-
centrations of [Nle4, D-Phe7]-K-MSH (NDP-MSH, Sigma, Saint
Louis, MO, USA), ranging from 10312 to 1036 M and a ¢xed amount
of [125I]NDP-MSH (Amersham Pharmacia Biotech, Little Chalfont,
Buckinghamshire, UK), corresponding to 10310 M and 0.1 WCi/well,
in a ¢nal volume of 500 Wl RPMI. Cells were then washed twice with
RPMI for 5 min at room temperature, and trypsinized. The cell sus-
pension was pipetted into plastic tubes and the associated radioactiv-
ity was measured. Non-speci¢c binding was estimated from the radio-
activity bound in the presence of 1036 M NDP-MSH or to cells
transfected with empty pcDNA and incubated with [125I]NDP-MSH
alone, with similar results.
2.5. Determination of agonist-induced cAMP increases
Cells grown as above and serum-deprived for 24 h were incubated
with 10313^1037 M NDP-MSH, for 20 min. Then, the medium was
aspirated, cells quickly washed with 1 ml ice-cold PBS, lysed with 350
Wl preheated 0.1 N HCl (70‡C), and carefully scraped. The resulting
mix was freeze-dried for 2 h, washed with 100 Wl H2O, and freeze-
dried for another 30 min. Dried samples were dissolved in suitable
volumes of 50 mM Tris, 4 mM EDTA, pH 7.5, from 65 to 300 Wl,
depending on the expected cAMP content. cAMP was measured by
radioimmunoassay (Amersham Pharmacia Biotech), as per instruc-
tions. Parallel dishes for protein determination were included. Cells
were dissolved in 10 mM phosphate bu¡er pH 7, 1% Igepal CA-640,
containing 0.1 mM EDTA, and 0.1 mM PMSF. The protein concen-
tration in these lysates was determined by the bicinchoninic acid
method.
3. Results and discussion
Sequencing of the complete MC1R open reading frame
from a small sample of ¢ve skin type I or II individuals,
and ¢ve others with skin type III or IV con¢rmed that
MC1R allelic variants are common in fair skin subjects, but
not in individuals with darker skin and high tanning ability.
Table 1
Frequency of the Ile40Thr, Val60Leu, Val92Met, and Val122Met MC1R allelic variants
Variant Frequency (% carriers)
Skin type Hair color Overall (n = 55)
Types I^II
(n = 28)
Types III^IV
(n = 27)
Fair
(n = 25)
Light brown
(n = 8)
Dark brown and
black (n = 19)
Red
(n = 3)
Ile40Thr 14.3 (4) 0 (0) 16 (4) 0 (0) 0 (0) 0 (0) 7.3 (4)
Val60Leu 17.8 (5) 11.1 (3) 24 (6) 0 (0) 10.5 (2) 0 (0) 14.5 (8)
Val92Met 10.7 (3) 3.7 (1) 12 (3) 0 (0) 5.3 (1) 0 (0) 7.3 (4)
Val122Met 14.3 (4) 7.4 (2) 12 (3) 0 (0) 10.5 (2) 33 (1) 10.9 (6)
A total of 55 healthy volunteers were classi¢ed into two groups according to skin type (types I^II and types III^IV), and into four groups ac-
cording to hair color. For convenience, and to avoid classi¢cation errors, no e¡ort was made to distinguish between skin types I or II, on one
hand, and III or IV, on the other. DNA was extracted from 3 ml blood samples. All AS-PCR reactions were performed with 0.5 Wg of target
DNA, as described in Section 2. The complete coding sequence of the MC1R gene from samples found positive for any one of the mutations
was ampli¢ed and sequenced for con¢rmation and identi¢cation of homozygote carriers. All carriers were heterozygous for the mutations under
study, carrying one mutant and one wild-type allele, except for one Val60Leu homozygote (skin type I^II, blond hair). Two other individuals
were compound heterozygotes, one for the Ile40Thr and Val60Leu variants and the other for the Val60Leu and Arg163Gln alleles, and both of
them had skin type I^II and blond hair.
n, number of individuals in each group. Allele frequencies are shown as percentage of individuals carrying at least one mutant allele, whose
number is shown in parentheses, with respect to the total population studied in each column.
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Whereas all ¢ve skin III^IV individuals were homozygous for
wild-type MC1R (GenBank accession number AF326275),
four skin I^II volunteers were heterozygotes harboring Val92-
Met (2/5), Ile40Thr (1/5) and Val122Met (1/5) alleles, and the
¢fth individual was a compound heterozygote for the Val60-
Leu and Arg163Gln alleles. These data are in agreement with
previous reports of a high frequency of MC1R variants in skin
I and II individuals [15^17]. Among these variants, Val60Leu,
Val92Met, and Arg163Gln have already been described. The
Arg163Gln variant is highly frequent in Asian population and
does not seem to have any relevant functional e¡ect [9,11].
Therefore, it was not included in our study. The Val60Leu
allele encodes a partial loss-of-function protein, with binding
properties almost identical to the wild-type, but a residual
signaling through the cAMP cascade [14], and no clear asso-
ciation with any particular skin type or hair color [13,15,17].
Concerning the Val92Met substitution, a study reported a
lower a⁄nity for K-MSH [20], whereas others did not ¢nd
signi¢cant functional changes [21]. In any case, this suggests
that the functional e¡ects of the Val92Met substitution, if
any, are small, a conclusion strengthened by association stud-
ies [17].
However, variants Ile40Thr and Val122Met have not been
found in previous studies involving a much larger number of
individuals. Therefore, we wished for con¢rmation of their
existence and for an estimation of their frequency, by per-
forming an AS-PCR analysis of a larger group. For compar-
ison, the well characterized Val60Leu and Val92Met alleles
were also analyzed. AS-PCR con¢rmed the sequencing data
(Fig. 1). The frequency data for the Val60Leu and Val92Met
alleles were in reasonable agreement with those reported by
others [17], thus validating the screening technique. Variants
Ile40Thr and Val122Met were more frequently found in skin
type I and II individuals (Table 1). This was particularly clear
for the Ile40Thr allele, that was found exclusively in skin type
I^II subjects, thus suggesting a possible association with fair
skin. However, the size of the population analyzed was rela-
tively small, and the P values obtained from the Fisher’s exact
test only approached signi¢cance for the Ile40Thr variant
(P = 0.06). Work is underway to increase the number of sam-
ples analyzed and con¢rm or disprove a possible association
of this allele with fair skin and/or blond hair. In any case, the
Ile40Thr and Val122Met alleles are relatively frequent, at least
in the Spanish population.
According to current models of the MC1R protein [3], Ile40
lies in the extracellular side of the ¢rst TM fragment (TM1),
and Val122 is located in TM3, next to Asp121, a residue
found to be critical for agonist binding by site-directed muta-
genesis studies [22]. TM1 and TM3 contain important deter-
minants for binding of agonists and e¡ective coupling to the
cAMP cascade [1]. Moreover, Ile40 and Val122 are highly
conserved residues, present in most mammalian MC1R genes
sequenced to date [1,3]. Ile40 is also present in the mouse and
human MC3 and MC5 receptors [3]. Therefore, we analyzed
the functional e¡ects of the Ile40Thr and Val122Met substi-
tutions.
The binding a⁄nity of the variants was studied by compe-
tition binding experiments performed with HEK 293T cells
transiently expressing the receptor protein (Fig. 2). Displace-
ment curves were signi¢cantly shifted to higher competing li-
gand concentrations, as compared to the wild-type. IC50 val-
Fig. 1. AS-PCR analysis of the Ile40Thr and Val122Met variants in
human genomic DNA. The size of the expected PCR fragments was
888 bp for the Ile40Thr allele (upper panel) and 645 bp for the
Val122Met variant (lower panel). Lane 1 in each panel shows the
migration of molecular size standards. The following lanes corre-
spond to a representative number of samples from di¡erent individ-
uals. In the two last lanes on the right, C stands for controls. These
were ascertained by complete sequencing of the MC1R gene, and
were included in each AS-PCR round. The positive control (+) con-
sisted of an identical amount of genomic DNA from an heterozy-
gote harboring one variant and one wild-type allele. The negative
control (3) corresponded to a wild-type homozygote. Aliquots (1/5
of the PCR reaction volume) were electrophoresed in 2% agarose
gels and ethidium bromide-stained. The negative of the stained gel
is shown, for easier visibility.
Table 2
Binding and coupling parameters of wild-type MC1R and the Ile40Thr and Val122Met variants transiently expressed in HEK 293 cells
Variant Bmax
(fmol/mg protein)
IC50 for displacement
by NDP-MSH (nM)
EC50 for cAMP
production (nM)
Maximal cAMP levels
(pmol/mg protein)
Wild-type 3270 þ 610 0.70 þ 0.12 0.011 þ 0.004 355 þ 60
Ile40Thr 4880 þ 870 2.66 þ 0.41** 1.10 þ 0.23** 326 þ 27
Val122Met 8440 þ 540 16.41 þ 3.4** 0.36 þ 0.09** 185 þ 56*
All data are given as mean þ S.E.M. (nv4). The statistical signi¢cance of the di¡erences in IC50, EC50 and maximal cAMP levels was assessed
by a one-tailed Student’s t-test.
*P6 0.05.
**P6 0.005.
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ues for [125I]NDP-MSH displacement by unlabeled NDP-
MSH were 7.0U10310 M for the wild-type, 2.7U1039 M for
Ile40Thr and 1.6U1038 M for Val122Met (Table 2). There-
fore, the Val122Met allele results in a clear reduction in a⁄n-
ity for NDP-MSH, whereas this e¡ect is lower, although sta-
tistically signi¢cant, for the Ile40Thr form. An e¡ect on
a⁄nity for agonists is not surprising for the Val122Met sub-
stitution, since Asp121 is a major determinant of hormone
binding [3,22], so that a mutation close to this residue, which
is thought to interact with the hormone, can easily impair
ligand docking. The loss of a⁄nity of the Ile40Thr variant
is less marked, but still evident. Interestingly, computer mod-
eling of the MC1R three-dimensional structure suggests that a
cavity formed between TM1 and TM3 is important for bind-
ing to the melanocortins core sequence. Within this cavity,
residues Leu48, Ser52 and Glu55 in TM1 are thought to in-
teract with the ligand, and all these residues are located in the
same side of the predicted helical structure as Ile40 [3].
The functional coupling of the Ile40Thr and Val122Met
variants was then analyzed. HEK 293T cells were transiently
transfected with the wild-type, Ile40Thr and Val122Met
forms, and their cAMP levels in response to increasing doses
of NDP-MSH were measured (Fig. 3). Both mutant receptors
displayed a rightward shift in the dose^response curves, with
signi¢cant changes in the EC50 for agonist-induced cAMP
accumulation (1.1U10311 M for wild-type, 1.1U1039 M for
Ile40Thr and 3.6U10310 M for Val122Met). Moreover, the
basal and maximal hormone-induced cAMP levels were sim-
ilar for wild-type and Ile40Thr receptors, but signi¢cantly
lower for the Val122Met mutant (Fig. 3 and Table 2).
A comparison of the shifts in IC50 for agonist displacement
and EC50 for cAMP production, together with the maximal
levels of cAMP achieved after stimulation with saturating
doses of NDP-MSH, prove that the functional e¡ects of the
two mutations are di¡erent. The a⁄nity of Ile40Thr MC1R
for NDP-MSH is decreased less than four-fold, as compared
to the wild-type. Conversely, the EC50 for coupling to the
cAMP-generating system is increased about 100-fold. There-
fore, much higher fractional occupancies of MC1R seem nec-
essary for the Ile40Thr variant to achieve similar cAMP re-
sponses as the wild-type receptor. These data strongly suggest
that the Ile40Thr substitution not only impairs hormone bind-
ing, but also decreases the ability of the hormone^receptor
complex to undergo the conformational change leading to
receptor activation and e⁄cient coupling to GS. Conversely,
the a⁄nity of the Val122Met for NDP-MSH, and the EC50
value for coupling to cAMP production are a¡ected to ap-
proximately the same extent. This suggests that the rightward
shift in the cAMP dose^response curve for this mutant is
accounted for by decreased binding a⁄nity. But, in this
case, the maximal levels of cAMP elicited by saturating doses
of the agonist are lower than for the wild-type. Therefore, the
¢nal active conformational state of the Val122Met mutant
seems less e⁄cient in GS activation, in a way reminiscent of
the situation observed after binding of partial agonists to
other GPCRs.
Natural MC1R mutations leading to impaired coupling
without noticeable e¡ects on agonist binding a⁄nity have
been described [14]. This, together with the results presented
here, shows that natural loss-of-function mutations impairing
virtually all the steps of MC1R activation are actually present.
Their study may help to reconcile occasional discrepancies
between data obtained by functional approaches in trans-
fected heterologous cells on one hand, and by analysis of
the association of particular variants with skin or hair pig-
mentation phenotypes, on the other. The functional analysis
of natural MC1R variants should therefore allow not only for
a better understanding of the genetic determinants of skin
type, hair color and UV response [23], but also for a dissec-
tion at the molecular level of the mechanisms of MC1R acti-
vation. Interestingly, and quite surprisingly in the light of the
frequent loss-of-function mutations and of the high human
MC1R gene polymorphism, no activatory mutation such as
the ones described for the mouse gene has been described so
far.
Fig. 2. Binding of NDP-MSH to wild-type MC1R and the Ile40Thr
and Val122Met variants. Measurements were performed in quadru-
plicate independent dishes. The results were ¢tted to a one site com-
petition binding curve, using GraphPad Prism 2.01 (GraphPad Soft-
ware, San Diego, CA, USA). Error bars indicate S.E.M. F, wild-
type; P, Ile40Thr; a, Val122Met.
Fig. 3. Functional coupling of the Ile40Thr and Val122Met variants.
HEK 293T cells transfected with the wild-type and mutant forms,
and treated with 10313^1036 M NDP-MSH, for 20 min, prior to ly-
sis and determination of their cAMP contents. Each measurement
was performed in duplicate or triplicate independent wells, and the
complete set of measurements was repeated at least twice (nv4). Re-
sults were ¢tted to a sigmoidal dose^response curve. Error bars in-
dicate S.E.M. F, wild-type; P, Ile40Thr; a, Val122Met.
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